Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vivo Bio tech Ltd. Regulatory Filings 2025

Nov 4, 2025

61184_rns_2025-11-04_0259eac9-969a-4fb1-83b8-86aa33d893ef.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [299 x 72] intentionally omitted <==

November 04, 2025

To, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 Scrip Code: 511509

Dear Sir/Madam,

Subject : Intimation of date of the Board Meeting

Reference : Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

With reference to the above subject, this is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 14, 2025 at the Registered Office of the Company, inter-alia

1. To consider and approve the Un-Audited Standalone & Consolidated Financial Results of the Company for the Second Quarter and Half Year ended September 30, 2025.

Please be informed that the trading window of Vivo Bio Tech Limited shall remain closed for all Directors, Promoters, Designated Employees and Specified Connected Persons of the Company till November 16, 2025 in view of the aforesaid Board Meeting.

This is for your information and records.

Thanking You,

Yours faithfully

For Vivo Bio Tech Limited

Ayinampud Digitally signed by Ayinampudi i Vaishnavi Vaishnavi Kiran Date: 2025.11.04 Kiran 15:04:29 +05'30' A V Kiran Company Secretary

==> picture [596 x 85] intentionally omitted <==